Evidence map›Paper›PMID 33276835›Full record

ArticleMayo Clinic proceedings2020

A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality.

Thoetchai Bee Peeraphatdit, Joseph C Ahn, Dae Hee Choi, Alina M Allen, Douglas A Simonetto, Patrick S Kamath, Vijay H Shah

Abstract read
PubMed Publisher
In one paragraph

Article in Mayo Clinic proceedings, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Envisioning how to advance the MASH field.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  5. Review
  6. Alcohol Use Disorder and Alcohol-Associated Liver Disease.Alcohol research : current reviews · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Thoetchai Bee PeeraphatditDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN; Center for Liver Diseases, University of Chicago Medicine, Chicago, IL.
Joseph C AhnDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Dae Hee ChoiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Alina M AllenDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Douglas A SimonettoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Patrick S KamathDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Vijay H ShahDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN. Electronic address: shah.vijay@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the interaction of alcohol consumption with body mass index (BMI) in the development of hepatic steatosis and mortality. PARTICIPANTS AND

methodsWe conducted a retrospective cohort study of 18,506 participants without fatty liver disease or cirrhosis at enrollment in the Mayo Clinic Biobank from April 9, 2009, through March 31, 2016. Participants were classified by self-reported alcohol consumption status (nondrinkers, moderate drinkers [0 to 2 drinks per day], and heavy drinkers [>2 drinks per day]). The primary outcome of interest was the incidence of hepatic steatosis, identified by International Classification of Diseases, Ninth Revision code and confirmed with imaging. The secondary outcome of interest was all-cause mortality. Multivariate Cox regression analysis determined the impact of alcohol consumption stratified by BMI on outcomes compared with nondrinkers.

resultsThe cohort (mean ± SD age, 55.8±16.9 years; 63.8% female; mean ± SD BMI, 28.8±6.1 kg/m

conclusionIn obese individuals, even moderate alcohol use is associated with the development of hepatic steatosis. Moderate alcohol consumption is associated with lower mortality in normal-BMI and overweight individuals but not in those who are obese.

Indexed as

Alcohol DrinkingObesityBody Mass IndexFatty LiverFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedMortalityRisk AssessmentRisk FactorsUnited States

Identifiers

PMID33276835
OpenAlexW3109419080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.